English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A type C virus was isolated from C3H/10T1/2 mouse cells in culture after activation with iododeoxyuridine. This virus was poorly infectious for mouse cells and did not cause tumors upon inoculation into newborn NIH Swiss mice. Variants with increased infectivity for mouse cells were then derived both in vivo and in vitro by selecting for variants able to grow to high titers. The highly infectious variants were found to induce mouse fibroblasts to grow in soft agar. When the viruses were inoculated into newborn NIH Swiss mice, 100% of the animals died of leukemia within 4 months. Solid tumors developed at the injection site. Both mouse-tropic and dualtropic viruses were isolated from the leukemic mice and plaque purified. The first group of viruses produced large syncytial plaques on rat XC cells and did not grow in mink cells. The viruses of the other group replicated well in both mouse and mink cells, producing morphologic changes similar to transformation but not XC syncytia; they, therefore, are members of the newly described MCF class of mouse type C viruses. Isolates from either group were highly leukemogenic on retesting, the mean latent period being 67 days for a mouse-tropic virus and 105 days for one of the dual-tropic viruses. The results led to the conclusion that the better a mouse type C virus grows in cell culture the more effective it is as a leukemogen. Further, it is possible to start with a weakly infectious, nonleukemogenic virus and to convert it to a rapidly replicating, highly leukemogenic virus by passage either in cell culture or in the animal. The availability of a defined series of viruses from a low-leukemia mouse strain that differ greatly in their biologic properties should facilitate studies of the molecular basis for the acquisition of type C virus oncogenicity.

Generation of oncogenic type C viruses: Rapidly leukemogenic viruses derived from C3H mouse cells in vivo and in vitro